| 1 |
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis
Vincent Daniels, Kunal Saxena, Craig S. Roberts et al. · Vaccine
Open access |
6 Apr 2021 |
109 |
| 2 |
Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments
Jakko van Ingen, M Obradović, Mariam Hassan et al. · Expert Review of Respiratory Medicine
Open access |
8 Oct 2021 |
69 |
| 3 |
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape
Derek P. de Winter, Allysen Kaminski, May Lee Tjoa et al. · BMC Pregnancy and Childbirth
ReviewOpen access |
7 Jan 2023 |
68 |
| 4 |
Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review
Shirley P. Huang, Sonya J. Snedecor, Sakina Nanji et al. · Rheumatology and Therapy
ReviewOpen access |
21 May 2022 |
38 |
| 5 |
Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective
Adnan Alsumali, Laurence M. Djatche, Andrew H. Briggs et al. · PharmacoEconomics
Open access |
8 Oct 2021 |
34 |
| 6 |
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up
К. Ray Chaudhuri, Angelo Antonini, Rajesh Pahwa et al. · Journal of Parkinson s Disease
ReviewOpen access |
12 Jul 2022 |
26 |
| 7 |
Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)
Vallerie V. McLaughlin, Adnan Alsumali, Rongzhe Liu et al. · Advances in Therapy
Open access |
18 Oct 2023 |
23 |
| 8 |
Human Papillomavirus Vaccine Impact and Effectiveness in Six High-Risk Populations: A Systematic Literature Review
Elizabeth Goodman, Miriam Reuschenbach, Allysen Kaminski et al. · Vaccines
ReviewOpen access |
16 Sep 2022 |
23 |
| 9 |
Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
Aubrey Manack Adams, Susan R. Hutchinson, Ella Engstrom et al. · The Journal of Headache and Pain
Open access |
3 Aug 2023 |
22 |
| 10 |
Injectable Hypomethylating Agents for Management of Myelodysplastic Syndromes: Patients’ Perspectives on Treatment
Amer Methqal Zeidan, Sayeli P. Jayade, Jordana K. Schmier et al. · Clinical Lymphoma Myeloma & Leukemia
Open access |
11 Sep 2021 |
21 |
| 11 |
Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea
Sarah M. Ronnebaum, Morgan Bron, Dipen A. Patel et al. · Journal of Clinical Sleep Medicine
Open access |
17 Aug 2021 |
21 |
| 12 |
Patient Preferences for Benefits, Risks, and Administration Route of Hypomethylating Agents in Myelodysplastic Syndromes
Amer Methqal Zeidan, Jui‐Hua Tsai, Milad Karimi et al. · Clinical Lymphoma Myeloma & Leukemia
Open access |
2 May 2022 |
17 |
| 13 |
Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer who are microsatellite instability (MSI)-high or are mismatch repair deficient (dMMR) in the United States
Sneha S. Kelkar, Vimalanand S. Prabhu, Shelby L. Corman et al. · Gynecologic Oncology
Open access |
4 Nov 2022 |
16 |
| 14 |
Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE
Richard B. Lipton, Janette Contreras‐De Lama, Daniel Serrano et al. · Neurology and Therapy
Open access |
Nov 2023 |
15 |
| 15 |
Psychosocial health modifies associations between HPA-axis function and brain structure in older age
Isabelle F. van der Velpen, Maud de Feijter, Rutika Raina et al. · Psychoneuroendocrinology
Open access |
3 Apr 2023 |
15 |
| 16 |
Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
Sneha S. Kelkar, Vimalanand S. Prabhu, Jingchuan Zhang et al. · Gynecologic Oncology Reports
Open access |
17 Jun 2022 |
15 |
| 17 |
Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma
Nitya Nathwani, Jill A. Bell, Dasha Cherepanov et al. · Supportive Care in Cancer
Open access |
Apr 2022 |
15 |
| 18 |
Cost impact of hydroxocobalamin in the treatment of patients with known or suspected cyanide poisoning due to smoke inhalation from closed-space fires
Kafi N. Sanders, Jyoti Aggarwal, Jennifer M.L. Stephens et al. · Burns
Open access |
6 Nov 2021 |
13 |
| 19 |
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017–2019
Nancy S. Reau, Mark Sulkowski, Emmanuel Thomas et al. · Advances in Therapy
Open access |
27 Oct 2021 |
13 |
| 20 |
Role of integrative medicine in the continuum of care of breast cancer patients in the Indian context
Partha Sarathi Basu, Richa Tripathi, Ravi Mehrotra et al. · Cancer Causes & Control
|
2 Feb 2021 |
13 |
| 21 |
Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe
Sneha S. Kelkar, Vimalanand S. Prabhu, Jingchuan Zhang et al. · Archives of Gynecology and Obstetrics
Open access |
18 Apr 2024 |
11 |
| 22 |
An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1
Lee Alexandra Evitt, Sakina Nanji, Richard A. Grove et al. · AIDS Research and Therapy
Open access |
22 Mar 2023 |
11 |
| 23 |
Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
Dipen A. Patel, Stéphan Martin, Michelle Luo et al. · Crohn s & Colitis 360
ReviewOpen access |
Jul 2022 |
11 |
| 24 |
The budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States
Sepehr Farahbakhshian, Timothy J. Inocencio, GREGORY WYATT POORMAN et al. · Journal of Medical Economics
Open access |
25 May 2022 |
10 |
| 25 |
A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia.
Esther Natalie Olíva, Sarah M. Ronnebaum, Omer Zaidi et al. · PubMed
ReviewOpen access |
2021 |
10 |
| 26 |
Quality-adjusted time without symptoms or toxicity analysis of nivolumab plus chemotherapy versus chemotherapy alone for the management of previously untreated patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma
Daniel Lin, Hiep P. Nguyen, Ruchit Shah et al. · Gastric Cancer
Open access |
21 Mar 2023 |
9 |
| 27 |
Monte Carlo Processing on a Chip (MCoaC)-preliminary experiments toward the realization of optimal-hardware for TOPAS/Geant4 to drive discovery
Yogindra Abhyankar et al. · Physica Medica
Open access |
16 Jul 2019 |
9 |
| 28 |
Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
Giuseppe Patti, Rosa Wang, Xiaocong Li Marston et al. · Cardiology and Therapy
Open access |
3 May 2023 |
8 |
| 29 |
Quality-Adjusted Time without Symptoms or Toxicity: Analysis of Axicabtagene Ciloleucel versus Standard of Care in Patients with Relapsed/Refractory Large B Cell Lymphoma
Marie José Kersten, Yao Qiao, Ruchit Shah et al. · Transplantation and Cellular Therapy
Open access |
13 Jan 2023 |
8 |
| 30 |
Physician preferences for attributes of pediatric combination vaccines in the United States
Salome Samant, Tanaz Petigara, Jyoti Aggarwal et al. · Current Medical Research and Opinion
Open access |
27 May 2022 |
8 |
| 31 |
Real-World Clinical and Economic Outcomes Associated with Surgiflo® vs Floseal in Cardiovascular Surgeries in the US
Walter Danker III, Jyoti Aggarwal, Sneha S Kelkar et al. · ClinicoEconomics and Outcomes Research
Open access |
Mar 2022 |
8 |
| 32 |
Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis
Bob G. Schultz, I. Diakité, John A. Carter et al. · Journal of Managed Care & Specialty Pharmacy
Open access |
29 Oct 2021 |
8 |
| 33 |
Current Treatment Paradigms and Clinical Outcomes in Oligometastatic Prostate Cancer Patients: A Targeted Literature Review
Emmanuel S. Antonarakis, Irene M. Shui, Omer Zaidi et al. · European Urology Oncology
|
3 Jul 2024 |
7 |
| 34 |
Pattern recognition in the landscape of seemingly random chimeric transcripts
Aksheetha Sridhar, Ankita S. More, Amruta R. Jadhav et al. · Computational and Structural Biotechnology Journal
Open access |
2023 |
7 |
| 35 |
Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome
Steven H. Abman, Nicholas R Fox, Mehreen Malik et al. · Drugs in Context
Open access |
8 Apr 2022 |
7 |
| 36 |
Patient Characteristics and Risk Factors in Invasive Mold Infections: Comparison from a Systematic Review and Database Analysis
Anita Sung, Stéphan Martin, Bryant Phan et al. · ClinicoEconomics and Outcomes Research
ReviewOpen access |
Jun 2021 |
7 |
| 37 |
Real-world treatment patterns and clinical outcomes in patients with advanced or recurrent endometrial cancer re-challenged with platinum-based chemotherapy in Europe
Vimalanand S. Prabhu, Sneha S. Kelkar, Jingchuan Zhang et al. · International Journal of Gynecological Cancer
Open access |
23 Jan 2025 |
6 |
| 38 |
Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017–2019
Michael Girardi, Kacie R. Carlson, Xingyue Huang et al. · Journal of Dermatological Treatment
Open access |
9 Jun 2024 |
6 |
| 39 |
Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery
Walter Danker, Sneha S. Kelkar, Xiaocong Li Marston et al. · Journal of Comparative Effectiveness Research
Open access |
28 Oct 2022 |
6 |
| 40 |
Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes
Amer Methqal Zeidan, Namita Joshi, Hrishikesh P. Kale et al. · Clinical Lymphoma Myeloma & Leukemia
Open access |
22 Apr 2022 |
6 |
| 41 |
Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial
Viktor Chirikov, Chris Walker, Jennifer M.L. Stephens et al. · ClinicoEconomics and Outcomes Research
Open access |
May 2021 |
6 |
| 42 |
Physician Perceptions, Knowledge, and Implementation of Lipid-Lowering Guidelines in the USA
Taruja D. Karmarkar, Lori D. Bash, Jason Exter et al. · Journal of General Internal Medicine
Open access |
25 Jul 2025 |
5 |
| 43 |
Posaconazole effectiveness in rare invasive fungal infections: A systematic literature review
Mark J. Bernauer, Hetty A. Waskin, Nicole Cossrow et al. · International Journal of Antimicrobial Agents
Review |
27 Feb 2025 |
5 |
| 44 |
Treatment patterns and burden of uncomplicated urinary tract infection in England: a retrospective cohort study
Mark H. Wilcox, Dave Heaton, Aruni Mulgirigama et al. · BJGP Open
Open access |
12 Dec 2024 |
5 |
| 45 |
Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis
Noa Krugliak Cleveland, Ninfa M. Candela, John A. Carter et al. · Crohn s & Colitis 360
Open access |
Oct 2024 |
5 |
| 46 |
Systematic Literature Review of Trials Assessing Recommended Systemic Treatments in Hepatocellular Carcinoma
Sarah M. Ronnebaum, Abdalla Aly, Dipen A. Patel et al. · Hepatic Oncology
ReviewOpen access |
26 Aug 2021 |
5 |
| 47 |
Effectiveness and Safety of Treatments for Early‐Stage Merkel Cell Carcinoma: A Systematic Review and Meta‐Analysis of Randomized and Non‐Randomized Studies
Yves Paul Vincent Mbous, Rowida Mohamed, Usha Sambamoorthi et al. · Cancer Medicine
ReviewOpen access |
2025 |
4 |
| 48 |
Real-world treatment patterns and clinical outcomes from a retrospective chart review study of patients with recurrent or advanced endometrial cancer who progressed following prior systemic therapy in Europe
Jingchuan Zhang, Sneha S. Kelkar, Vimalanand S. Prabhu et al. · BMJ Open
Open access |
Apr 2024 |
4 |
| 49 |
Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Variant Transthyretin Amyloid Cardiomyopathy
Nicholas S. Streicher, Leslie Amass, Rong Wang et al. · Cardiology and Therapy
Open access |
23 Mar 2024 |
4 |
| 50 |
Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer
Jamie Garside, Qin Shen, Bernd Westermayer et al. · Clinical Therapeutics
Open access |
15 Sep 2023 |
4 |